Columns

Pharma Insights
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic
Elizabeth Oyekan, PharmD, FCSHP, CPHQ February 22, 2021
Clinical Pathways GPS
Clinical Pathways and Policy to Guard Against Misaligned Incentives
Mathew Pakizegee, PharmD, MS; Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor; Seth Gordon, MBA, February 18, 2020
Moving forward, the more diligent payers and integrated delivery networks can be in evaluating and incorporating…
Patient Perspective
A Framework for Person-Centered Care Pathways in Oncology
Alan Balch, PhD—Column Editor, February 18, 2020
Alan Balch, PhD, outlines a proposed framework for how clinical pathways developers in oncology can better integrate…
Business of Pathways
Health Care as a Preexisting Financial Condition: Individual Costs and Societal Benefits
Sean McElligott, MS; Ira Klein, MD, MBA, FACP—Column Editor, December 17, 2019
Sean McElligott, MS, and Ira Klein, MD, MBA, FACP, assert that health care is inescapably a preexisting financial…
Trending From ACCC
Susan Dentzer to Address Disruptive Innovations and the Future of Cancer Care at ACCC 46th Annual Meeting & Cancer Center Business Summit
JCP Editors, December 17, 2019
This spring, ACCC will feature Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy, at…
Clinical Pathways GPS
Speaker Pelosi’s Plan to Lower Drug Costs
Matthew Pakizegee, PharmD, MS; Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor, November 18, 2019
Matthew Pakizegee, PharmD, MS, and Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD, review a government plan that…
Pharma Insights
How Development of Gene Therapies Impact Decisions on Their Place in Therapy
Larry Blandford, PharmD—Column Editor; Aaron Burke, November 18, 2019
Larry Blandford, PharmD, explores critical factors in the development of gene therapies and discusses the implications…
Trending From ACCC
ACCC Spotlights Strategies to Improve Care for Senior Adults With Cancer
JCP Editors, November 18, 2019
A new column from ACCC sheds light on how combined efforts of geriatric oncology researchers and organizations have…
CME Corner
An Update on Treatment Approaches Across the Multiple Myeloma Spectrum
Jonathan L Kaufman, MD, November 18, 2019
Jonathan L Kaufman, MD, discusses the relapse and refractory treatment landscape for multiple myeloma and standardizing…
Editorial
Potential or Unnecessary Burdens and Challenges for Practices Under Proposed CMS Radiation Oncology Model
Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, October 18, 2019
COA hopes to work together with the administration to ensure the final RO Model is appropriately flexible for patients…
Tools for Transformation
Contemplating the Future of Oncology Pathways
Gordon Kuntz—Column Editor, October 18, 2019
Gordon Kuntz, Partner, Kuntz Consulting, projects the business and clinical developments of oncology pathways in the…
Back to Top